Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px

Organisation › Details

Apogenix AG

https://www.apogenix.com

	Start	2015-12-23 reorganised
	Predecessor	Apogenix GmbH
	Industry	BIOTECH
	Industry 2	asunercept (APG101)
	Person	Höger, Thomas (Apogenix 200511– CEO + CFO before since 10/00 DZ Bank before BASF/Knoll)
	Person 2	Willinger, Peter (Apogenix 201506– CFO before Sygnis Pharma + Lion Bioscience)

	Region	Heidelberg
	Country	Germany
	Street	584 Im Neuenheimer Feld
	City	69120 Heidelberg
		Address record changed: 2020-12-11

Basic data	Employees	B: 11 to 50 (2012-10-06)


		Record changed: 2020-12-11

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Apogenix AG

[1] Apogenix AG. (5/23/18). "Press Release: Apogenix Provides Update on Clinical Development of Asunercept". Heidelberg....
[2] Apogenix AG. (10/5/17). "Press Release: Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes". Heidelberg....
[3] Apogenix AG. (5/29/17). "Press Release: Apogenix Granted PRIME Designation by European Medicines Agency for Asunercept to Treat Glioblastoma". Heidelberg....
[4] Apogenix AG. (4/11/17). "Press Release: Apogenix Announces Initiation of Clinical Development for ABBV-621 to Treat Solid and Hematologic Tumors by Partner AbbVie". Heidelberg....
[5] Apogenix AG. (6/15/16). "Press Release: Apogenix Reports Topline Results from Phase I Trial in Myelodysplastic Syndromes with APG101". Heidelberg....
[6] Apogenix AG. (5/4/16). "Press Release: Apogenix to Present at Two Upcoming International Conferences". Heidelberg....
[7] Apogenix AG. (2/16/16). "Press Release: Apogenix Receives €3 Million Grant for the Development of a Companion Diagnostic Test for Lead Immuno-Oncology Candidate APG101". Heidelberg....
[8] Apogenix AG. (1/7/16). "Press Release: Apogenix Receives First Milestone Payment from Canbridge Licensing Agreement and Signs Amendment to Include Taiwan". Heidelberg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)